Genematrix Inc
109820
Company Profile
Business description
Genematrix Inc is a biotech company engaged in the development of the platform and molecular diagnostics products. Its products include NeoPlexTM STI-7 Detection kit, OmniPlex-HPV, PapilloTyper, HepB Typer-Adefovir, and HepB Typer-Precore among others.
Contact
700, Daewangpangyo-ro, Bundang-gu
Gyeonggi-do
Seongnam-si463-400
KORT: +82 316282000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
67
Stocks News & Analysis
stocks
Ask the analyst: How reliant are Guzman shares on international growth?
A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,006.80 | 116.00 | 1.30% |
| CAC 40 | 7,822.78 | 0.78 | 0.01% |
| DAX 40 | 24,275.63 | 95.30 | -0.39% |
| Dow JONES (US) | 44,302.01 | 182.48 | -0.41% |
| FTSE 100 | 8,983.91 | 11.27 | 0.13% |
| HKSE | 24,825.66 | 326.71 | 1.33% |
| NASDAQ | 20,887.83 | 2.18 | 0.01% |
| Nikkei 225 | 39,819.11 | 82.08 | -0.21% |
| NZX 50 Index | 12,880.40 | 25.01 | -0.19% |
| S&P 500 | 6,296.10 | 1.26 | -0.02% |
| S&P/ASX 200 | 8,757.20 | 118.20 | 1.37% |
| SSE Composite Index | 3,534.48 | 17.66 | 0.50% |